Share Prices & Company Research

Stockbroking

Advanced Oncotherapy

Current Price 40.00p Bid 38.00p Ask 40.00p Change 2.56%
Last Updated: 23/02/2020 06:34. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Advanced Oncotherapy plc (formerly CareCapital Group plc) is a provider of particle therapy in the treatment of cancer, which harnesses the very best in modern technology. Advanced Oncotherapy's R&D team, ADAM, in Geneva, focuses on the development of a proprietary proton accelerator - LIGHT (Linac Image Guided Hadron Technology). LIGHT accelerates protons to the energy levels achieved in legacy machines but in a compact and truly modular unit, offering significant cost advantages. LIGHT also delivers proton beams in a way that facilitates greater precision and electronic control, which are not achievable with currently available alternative technologies.

Financial Highlights Year Ended 31/12/2018

Turnover
£0.00m
Operating Profit
£-21.80m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-2.78

Key Personnel

Nicolas Serandour
Chief Operating Officer
Dr Michael Jeffrey Sinclair
Executive Chairman
Michael Stephen Bradfield
Non-Executive Director
Hans Henrik von Celsing
Non-Executive Director
Renhua Zhang
Non-Executive Director
Enrico Cipro Vanni
Non-Executive Director
Bo Gabriel Urwitz
Non-Executive Director
Dr Peter Sigurd Ivar Sjostrand
Non-Executive Director
Dr Piers Nicholas Plowman
Non-Executive Director
Prof Stephen Myers
Non-Executive Director
Dr Yuelong Huang
Non-Executive Director
Chunlin Han
Non-Executive Director

Stock Details

EPIC
AVO
ISIN
GB00BD6SX109
Shares in Issue
244,423,406
Market cap
£95.33m

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
40.00p
Bid Price
38.00p
Ask Price
40.00p
Volume
177457
Change Today
1.00p
% Change Today
2.56%
Open
37.99p
Previous Close
40.00p
Intraday High
41.00p
Intraday Low
37.00p
52 Week High
52.00p
52 Week Low
32.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Advanced Oncotherapy Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
4.1
1.2
Intangible Assets & Goodwill
40.2
30.6
Investments & Other Non-Current Assets
1.5
1.2
Total Non-Current Assets
45.8
32.9
Inventory
10.0
7.6
Trade & Receivables
2.0
2.0
Cash & Receivables
1.0
0.1
Other Current Assets & Assets Held for Resale
0.7
2.9
Total Assets
59.5
45.4

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
9.0
16.7
Long Term Liabilities
16.5
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
25.5
16.7

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
34.0
28.7

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
42.4
20.2
Minority Interests
0.0
0.0
Retained Earnings
-78.8
-57.7
Share Premium Account
50.7
43.3
Other Equity
19.7
22.9
Total Equity
34.0
28.7

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
-1.7
-9.6
Cashflow Before Financing
-13.8
-18.2
Increase / Decrease in Cash
0.9
-1.4

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
0.0
0.0
Cost of Sales
1.9
0.0
Gross Profit
-1.9
0.0
Operating Profit
-21.8
-14.4
Pre-Tax Profit
-21.9
-16.5
Profit / Loss for the Year
-21.2
-13.7
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.